As mpox cases rise in Canada and globally, the World Health Organization (WHO) has once again declared the virus a global public health emergency. The surge in cases, particularly in Africa, has prompted concern among health officials as the virus continues to spread, including in cities like Toronto.
Mpox, previously known as monkeypox, was first identified in monkeys in 1958 and was primarily confined to central and western Africa. However, the virus began spreading rapidly worldwide in 2022. It belongs to the same family of viruses as smallpox and typically causes symptoms like rashes, fever, headaches, and muscle aches, with most people recovering within two to four weeks.
In Canada, Toronto Public Health is urging eligible residents to get vaccinated with the Imvamune vaccine, which provides protection against both smallpox and mpox. The vaccine is especially recommended for those at high risk of exposure. Health officials also highlight the availability of the antiviral drug tecovirimat for individuals experiencing severe symptoms.
Africa has seen a dramatic increase in mpox cases, with over 14,000 infections and 524 deaths reported this year, a 160 percent increase from the previous year. The outbreak in Africa is particularly concerning due to the emergence of a more transmissible and deadly strain of the virus.
In Canada, the first significant mpox outbreak occurred in 2022-2023, primarily affecting gay and bisexual men. Although cases initially declined, there has been a resurgence since early 2024, with a noticeable spike in infections during the summer months, particularly in Toronto.
Health officials continue to monitor the situation closely, urging Canadians to stay informed, get vaccinated, and take precautions to prevent the spread of mpox.